AG真人官方

Resideo Technologies (REZI) has filed a Form 144 notifying the SEC of an intended sale of 47,000 common shares, valued at approximately $1.15 million. The shares are to be sold through Morgan Stanley Smith Barney on or about 30 Jul 2025 immediately after the exercise of stock options. No other sales by the filer were reported in the prior three-month period.

The proposed transaction represents roughly 0.03 % of REZI鈥檚 148.5 million shares outstanding, making it immaterial to the company鈥檚 capital structure. The filer affirms awareness of no undisclosed adverse information, and no Rule 10b5-1 plan details are provided. Overall, the notice is procedural and does not affect Resideo鈥檚 fundamentals; it simply discloses an insider鈥檚 intent to convert options and divest a small stake under Rule 144.

Resideo Technologies (REZI) has struck a definitive deal to cap its legacy Honeywell environmental obligations. Under a Termination Agreement signed 30 Jul 25, subsidiary Resideo Intermediate Holding will make a one-time cash payment of $1.59 billion to Honeywell no later than 29 Aug 25, after which the 2018 Indemnification & Reimbursement Agreement and all related guarantees will be cancelled. The regular 3Q25 installment of $35 million was paid 29 Jul 25; all further scheduled payments are tolled until closing and forgiven if the deal completes.

To fund the payment, Resideo and Resideo Funding Inc. obtained a debt commitment letter for a new $1.225 billion senior secured term loan from JPMorgan and Wells Fargo, to be issued under the existing credit agreement. Concurrent amendments will: (i) raise incremental debt capacity and (ii) lift the revolving facility鈥檚 max leverage covenant to 4.0脳 for the 30 Sep 25 and 31 Dec 25 test dates with two optional 0.5脳 step-ups after material acquisitions. If lenders do not approve these changes, back-stop facilities will refinance the current term loan and revolver.

The Agreement may be terminated under specified conditions; failure to close combined with unavailable debt financing would trigger a $100 million liquidated damages fee and reinstate the indemnity. Separately, Resideo announced plans to spin off its ADI Global Distribution unit and provided preliminary June-quarter results (details in Exhibits 99.1鈥�99.2).

IQVIA Holdings Inc. (IQV) 鈥� Form 4 insider transaction

Executive Vice President & General Counsel Eric Sherbet exercised 11,870 Stock Appreciation Rights (SARs) at an exercise price of $97.20 on 07/23/2025, converting them into an equal number of common shares.

Immediately after the exercise, Sherbet:

• Sold 5,800 shares at a weighted-average $190.05 (range $189.99鈥�$190.18), generating roughly $1.1 million in gross proceeds.
• Disposed of 6,070 shares at $190.10, likely for tax-withholding.

Following the transactions, Sherbet鈥檚 direct ownership decreased to 21,108 common shares; all SARs from the 03/01/2021 grant are now fully exercised, leaving zero derivative securities outstanding.

The activity represents a net sale of the entire 11,870 shares obtained through exercise, with no new open-market purchases. While the executive retains a meaningful equity stake (鈮�$4.0 million at $190), the sale may signal profit-taking rather than incremental confidence.

Auddia Inc. is calling its 2025 Annual Meeting for September [***], 2025 to vote on five key items.

Proposal 1: Elect four directors鈥擩effrey Thramann (now CEO), Nick Balletta, Emmanuel de Boucaud and Joshua Sroge鈥攆ollowing the July 2025 retirement of the prior CEO and three director resignations.
Proposal 2: Ratify Haynie & Company as auditor for FY 2025.
Proposal 3: Approve an amendment to the existing equity line with White Lion Capital that (i) extends the term to 12/31/2027 and (ii) raises the total commitment from $10 million to $50 million. Shares will be priced at 85-90% of market VWAP and capped at 9.99% ownership per purchase notice, but overall issuance could exceed 20% of current outstanding shares, triggering Nasdaq Rule 5635(d) shareholder-approval requirements.
Proposal 4: Approve share issuance above the 19.99% Nasdaq cap related to the June 30, 2025 $750k Series C convertible preferred financing (10% annual dividend, $4.77 conversion price, 314,466 five-year warrants; anti-dilution resets down to $0.954 floor).
Proposal 5: Amend the 2020 Equity Incentive Plan to (a) add an unspecified number of new shares (bumping the reserve above 67,899) and (b) raise the individual annual grant limit from 29,412 shares to an undisclosed higher amount.

Only holders of record on July [***], 2025 may vote. The board recommends FOR all proposals. Investors should weigh enhanced capital flexibility and refreshed governance against substantial dilution risk from the ELOC, preferred stock and enlarged option pool.

Thermo Fisher Scientific (TMO) filed an 8-K announcing a planned CFO transition.

Senior Vice President & Chief Financial Officer Stephen Williamson will retire effective March 31 2026. To provide continuity, the board has appointed James R. Meyer (age 46), currently Vice President, Financial Operations, to become Senior Vice President & CFO effective March 1 2026. Meyer joined the company in 2009 and has held progressively senior finance roles, including VP of Finance, Customer Channels (2020-2022), before assuming his present post in January 2023; he previously worked at PwC.

No financial results, guidance, debt transactions or other material events were disclosed. The orderly, internally sourced succession suggests minimal operational disruption, although leadership change can introduce short-term uncertainty. Compensation or severance terms were not included in this filing.

Resideo Technologies, Inc. (REZI) has filed a Form 4 reporting a modest insider sale by director Nina Richardson.

On 07/07/2025, Richardson sold 2,790 shares of common stock at a weighted-average price of $23.68. The disposition was executed under a Rule 10b5-1 trading plan adopted on 11/27/2024, indicating the trade was pre-arranged and not the result of real-time information.

Following the sale, the director鈥檚 direct holding stands at 64,008 shares, implying the transaction reduced her stake by roughly 4 %. No derivative transactions were reported.

The filing, signed on 07/09/2025 by an attorney-in-fact, contains no additional material events or financial data.

Resideo Technologies, Inc. (REZI) filed a Form 144 disclosing a planned disposition of 5,579 common shares via Morgan Stanley Smith Barney on 07 July 2025. The stock originates from restricted stock units granted on 16 November 2022 and carries an estimated market value of $134,342. With 148,503,534 shares currently outstanding, the sale equals roughly 0.004 % of total shares鈥攁n amount generally viewed as immaterial to the company鈥檚 float. The filer reported no other sales in the past three months, and the notice contains no commentary on company operations or outlook.